Open AccessQualitative Perceptions of Dapivirine VR Adherence and Drug Level Feedback Following an Open-Label Extension Trial
Author(s) -
Kalendri Naidoo,
Leila E. Mansoor,
Ariana Katz,
Morgan Garcia,
Doreen Kemigisha,
Neetha Morar,
Chifundo Zimba,
Miria Chitukuta,
Krishnaveni Reddy,
Lydia SotoTorres,
Sarita Naidoo,
Elizabeth T. Montgomery
Publication year - 2021
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/qai.0000000000002590
Subject(s) - vaginal ring , distrust , medicine , blame , perception , human immunodeficiency virus (hiv) , qualitative research , family medicine , psychology , clinical psychology , psychiatry , family planning , environmental health , population , psychotherapist , research methodology , neuroscience , social science , sociology
There continues to be a need for HIV prevention options that women can initiate and use autonomously. The dapivirine vaginal ring (VR) has been shown to have a favorable safety profile and reduce the risk of HIV-1 acquisition. We report on women's experiences with VR adherence during the MTN-025/HIV Open-label Prevention Extension (HOPE) study and responses to Residual Drug Level (RDL) results.